📈 நேரலை சந்தை கண்காணிப்பு

NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.

நேரலை சமீபத்திய அறிவிப்பு: 5 நாட்களுக்கு முன் இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
பின்தொடர்Telegram
0
இன்று
168,672
இதுவரை பகுப்பாய்வு செய்யப்பட்டவை
49,863
நேர்மறை
8,485
எதிர்மறை
100,530
நடுநிலை
9,726
கண்காணி
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
அழி
87 அறிவிப்புகள் பொருந்தும் தாக்கம் 5+ Symbol: ACC
நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

Accuracy Shipping Q2 FY27 Consolidated PAT Rises 84% YoY to ₹1.10 Cr

Accuracy Shipping reported its Q2 FY27 (period ended September 30, 2026) results, with consolidated revenue from operations at ₹180.59 crore, down 5.4% YoY from ₹190.83 crore. Consolidated PAT jumped 84.4% YoY to ₹1.10 crore (₹11.01 million) compared to ₹0.60 crore in Q2 FY26, driven by higher margins in logistics services. On a standalone basis, revenue was ₹170.00 crore with a PAT of ₹0.34 crore (₹3.39 million), down from ₹0.80 crore YoY. Consolidated half-year PAT stood at ₹1.44 crore on revenue of ₹321.68 crore.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

Accord Synergy Approves H1 FY27 Results; Notes Resignation of Company Secretary

Accord Synergy Limited reported its unaudited standalone financial results for the half year ended September 30, 2026. The company noted that during the period it completed a preferential allotment of 4,00,000 equity shares at Rs 42.35 each, raising approximately Rs 1.69 crore. Additionally, the Board took note of the resignation of Ms. Drashti Gandhi as Company Secretary and Compliance Officer, effective November 30, 2026.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Accretion Pharma H1 FY27 Net Profit Rises 72.6% YoY to ₹8.20 Cr, Revenue Up 25.8%

Accretion Pharmaceuticals reported strong results for the half year ended September 30, 2026, with revenue from operations growing 25.8% YoY to ₹55.04 cr compared to ₹43.74 cr in H1 FY26. Net profit surged 72.6% YoY to ₹8.20 cr up from ₹4.75 cr, driven by operational leverage. Basic and diluted EPS improved to ₹7.38 from ₹4.61 in the corresponding previous half year. However, operating cash flow turned negative at -₹3.12 cr due to an increase in trade receivables to ₹31.98 cr.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

H1 FY27 PAT Jumps 72.63% to ₹8.20 Cr; Revenue Rises 25.83% to ₹55.04 Cr

Accretion Pharmaceuticals announced strong H1 FY27 financial results with net revenue rising 25.83% YoY to ₹55.04 crore compared to ₹43.74 crore in H1 FY26. EBITDA grew 72.28% YoY to ₹12.37 crore, resulting in an EBITDA margin expansion of 606 bps to 22.48%. Net profit (PAT) increased by 72.63% YoY to ₹8.20 crore, while basic EPS rose to ₹7.38 from ₹4.61. International operations gained traction, with exports nearly doubling to 18.15% of revenue from 9.16% in H1 FY26.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

Adani Cement Capacity Hits 113.5 MTPA; Q2 FY27 Ambuja Standalone PAT Falls 90% to ₹114 Cr

ACC released the Adani Cement group investor presentation for Q2 FY27 detailing operational performance and capacity expansion. Consolidated cement capacity reached 113.5 MTPA following the commercial commissioning of 4.6 MTPA in Q2 FY27, including ACC's 2.4 MTPA Salai Banwa grinding unit and 1.0 MTPA Kalamboli blending unit. A further 5.6 MTPA pipeline is planned for H2 FY27, alongside a 29.7 MTPA medium-term cement addition pipeline. In standalone figures for parent Ambuja Cements, Q2 FY27 revenue rose 10% YoY to ₹6,121 Cr, while PAT contracted 90% YoY to ₹114 Cr.

📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்

நேர்மறைஎதிர்மறைநடுநிலைகவனம்
எதிர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

ACC Reports Q2 FY27 PAT of ₹93 Cr; Commissions 3.4 MTPA Capacity as Merger Heads to NCLT

ACC announced its Q2 FY27 results, reporting revenue from operations of ₹5,689 Cr, down 5.3% YoY from ₹6,005 Cr, with PAT dropping sharply to ₹93 Cr from ₹1,119 Cr in Q2 FY26 (which included a ₹659 Cr tax reversal). Operating EBITDA contracted to ₹401 Cr with margins narrowing to 7.0% (down from 14.1% YoY) due to seasonal weakness and higher fuel costs of ₹1.81/'000 kCal. On operations, the company commissioned 3.4 MTPA of cement capacity (2.4 MTPA at Salai Banwa and 1.0 MTPA at Kalamboli). Additionally, shareholders approved the proposed merger with Ambuja Cements with over 95% votes in favor, moving the scheme to the NCLT for final approval expected in FY27.

எதிர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

ACC Q2 FY27 Net Profit Plunges 91% YoY to ₹101 Cr as Realisations and Margins Suffer

ACC Limited reported its standalone results for the quarter ended September 30, 2026, showing revenue from operations down 4.7% YoY to ₹5,612 crore compared to ₹5,890 crore in Q2 FY26. Standalone profit after tax fell drastically by 90.9% YoY to ₹101 crore, down from ₹1,112 crore in the corresponding prior-year quarter (which included a tax write-back of ₹671 crore). Standalone profit before tax dropped 83.0% YoY to ₹129 crore versus ₹757 crore, driven by margin compression and an exceptional expense of ₹71 crore. Basic EPS dropped to ₹5.38 from ₹59.22 in Q2 FY26.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

CreditAccess Grameen Q2 FY27 Net Profit Reaches Record ₹502 Cr; Raises FY27 ROE Guidance

CreditAccess Grameen posted a record quarterly PAT of ₹502 crore for Q2 FY27, bringing H1 FY27 net profit to ₹995 crore, up from ₹778 crore in the entire prior fiscal year. Total AUM grew 19.5% YoY to ₹30,946 crore with disbursements up 19.4% YoY to ₹6,355 crore. Asset quality improved sequentially with Gross NPA at 1.79% and Net NPA at 0.59%, while NIM expanded to 15.1%. Following strong performance, management increased its FY27 ROA guidance to 5.2%-5.8% (from 4.0%-4.8%) and ROE guidance to 21%-24% (from 16%-20%).

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

CreditAccess Grameen Q2 Net Profit Jumps to ₹501.57 Cr; Sharp & Tannan Named Joint Auditor for FY28

CreditAccess Grameen reported standalone net profit of ₹501.57 crore for Q2 FY27 (quarter ended Sep 30, 2026), marking a significant increase from ₹125.81 crore in Q2 FY26. Total income rose 26.2% YoY to ₹1,904.80 crore compared to ₹1,509.02 crore in the corresponding prior-year period. Impairment on financial instruments fell sharply to ₹299.23 crore from ₹525.67 crore in Q2 FY26. Alongside the results, the board approved the planned appointment of M/s Sharp & Tannan as Joint Statutory Auditor for a 3-year term starting FY28, replacing M/s Walker Chandiok & Co LLP upon completion of their tenure.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

CreditAccess Grameen Q2 FY27 PAT Jumps 298.7% YoY to ₹501.6 Cr; Raises FY27 Return Guidance

CreditAccess Grameen reported its highest quarterly Profit After Tax (PAT) of ₹501.6 crore for Q2 FY27, up 298.7% YoY from ₹125.8 crore. Assets Under Management (AUM) expanded 19.5% YoY to ₹30,946 crore, supported by a 19.4% rise in quarterly disbursements to ₹6,355 crore. Asset quality remained healthy, with GNPA and NNPA at 1.79% and 0.59% respectively, and credit costs decreasing 43.2% YoY to ₹299 crore. Following H1 PAT of ₹995 crore (surpassing full-year FY26 PAT of ₹778 crore), management raised its full-year FY27 ROA guidance to 5.2-5.8% and ROE guidance to 21.0-24.0%.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

Q1 Operating Income Rises to Rs 137.65 Cr; PAT Declines 5.3% QoQ to Rs 28.85 Cr

Accelya Solutions reported its financial results for the quarter ended September 30, 2026, with consolidated operating income reaching Rs 137.65 crore (Rs 1,376.47 million), up 8.3% QoQ from Rs 127.12 crore. Consolidated PAT decreased 5.3% sequentially to Rs 28.85 crore (Rs 288.48 million) compared to Rs 30.45 crore in the June 2026 quarter. Compared to the prior year period (Sep 2025 revenue of Rs 136.20 crore and PAT of Rs 29.61 crore), performance was largely flat to slightly positive on top line and marginally lower on PAT. The quarterly revenue constitutes roughly 25.9% of its TTM revenue base of Rs 532 crore.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Accent Microcell Reports H1 FY27 Revenue of ₹174.83 Cr, PAT Up 72.2% to ₹31.12 Cr

Accent Microcell released its H1 FY27 investor presentation, reporting revenue from operations of ₹174.83 Cr (₹17,483.09 lakh), up 25.4% YoY. Profit after tax jumped 72.2% YoY to ₹31.12 Cr (₹3,111.60 lakh), while EBITDA rose 65% YoY to ₹43.90 Cr with an EBITDA margin of 25.11% (up 609 bps). Premium products' share in revenue increased by 304 bps YoY to 13.52%, and exports constituted 72.34% of revenue. Unit III at Nayka, Kheda is currently under commissioning with Phase 1 adding 2,800 MTPA capacity.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Accent Microcell H1 FY27 Net Profit Rises 72% YoY to ₹31.12 Cr; Revenue Up 25% to ₹174.83 Cr

Accent Microcell reported standalone revenue from operations of ₹174.83 Cr for the half-year ended September 30, 2026, marking a 25.4% YoY increase compared to ₹139.37 Cr in H1 FY26. Standalone net profit surged 72.2% YoY to ₹31.12 Cr from ₹18.07 Cr, aided by lower finance costs and improved operational scale. Basic EPS improved to ₹12.97 compared to ₹7.84 in the prior-year period. Capital work-in-progress expanded to ₹134.66 Cr from ₹101.80 Cr in March 2026, driven by ongoing capacity additions.

நேர்மறை தாக்கம் 6/10 நிதி திரட்டல்

CreditAccess Grameen Secures USD 175 Million Syndicated Social Loan Facility

CreditAccess Grameen has signed a USD 175 million (~Rs 1,450+ crore) syndicated social loan facility qualifying as an External Commercial Borrowing (ECB) under the RBI automatic route. The facility secured participation from 10 financial institutions across Asia, the Middle East, and Africa, led by Standard Chartered Bank and DBS Bank. This marks the company's fifth ECB syndication, bringing cumulative mobilised funds via ECBs to USD 640 million over the past five years. Foreign borrowings currently constitute approximately 24% of the company's total liability profile.

நேர்மறை தாக்கம் 6/10 மற்றவை

AUM Grows 19.5% YoY to ₹30,946 Cr as PAR 90+ Drops to 1.1% in Q2 FY27 Update

CreditAccess Grameen released its interim business update for September 2026 (Q2 FY27), reporting an AUM of ₹30,946 Cr, up 19.5% YoY from ₹25,904 Cr. Quarterly disbursements increased 19.4% YoY to ₹6,355 Cr, with 2.3 lakh new borrowers added. Asset quality improved significantly, with PAR 90+ declining from 1.5% in Jun-26 to 1.1% in Sep-26, reaching 10-quarter lows despite heavy rainfall disruptions in select states. The Retail Finance (RF) portfolio expanded to ₹7,200 Cr, comprising 23% of total AUM compared to 11% in Sep-25.

நேர்மறை தாக்கம் 7/10 விரிவாக்கம்

ACC Commissions 2.4 MTPA Grinding Unit in UP & 3 MTPA Blending Unit in Maharashtra

ACC Limited has commissioned a 2.4 MTPA greenfield cement grinding unit at Salai Banwa, Uttar Pradesh. Additionally, its subsidiary, Bulk Cement (Corporation) India Limited, commissioned a 3.00 MTPA cement blending unit (adding 1.00 MTPA cement capacity) at Kalamboli, Maharashtra. This operationalization bolsters ACC's regional supply reach across northern and western markets, supporting its group-level volume growth targets against a TTM revenue base of Rs 25,351 Cr.

நேர்மறை தாக்கம் 9/10 M&A

Shareholders Approve ACC's Merger with Ambuja Cements with 84.97% Favour Votes

ACC Limited's equity shareholders have approved the Scheme of Amalgamation with parent entity Ambuja Cements Limited in an NCLT-convened meeting held on September 29, 2026. The resolution passed with an 84.97% overall majority of the votes polled (38,365,775 votes in favour vs 6,784,657 against). Institutional public shareholders voted 84.82% in favour, while non-institutional public shareholders approved it with 97.70% votes in favour. This marks a major milestone toward consolidating the Adani Group's flagship cement operations.

கண்காணிப்பு தாக்கம் 8/10 நிர்வாகம்

Accord Synergy Sees Mass Board Resignations Following Entry of New Promoter Faruk Patel

Accord Synergy announced the simultaneous resignations of four top board members on 16 September 2026: Chairman Asdullakhan Pathan, Managing Director Betulla Khan Asdulla, and Whole-time Directors Roli Khan Betulla and Ritu Chaudhari Negi. The departures follow the induction of Mr. Faruk Patel as a Promoter and are stated to be part of a strategic leadership restructuring. Despite a massive 762.5% stock rally over the past 12 months, the company remains thinly profitable, posting a TTM net profit of Rs 0 Cr on Rs 64 Cr revenue.

நேர்மறை தாக்கம் 8/10 விரிவாக்கம்

Accuracy Shipping Sub Gets LoI for Kandla CFS; Plans ₹25 Cr Capex, ₹175-200 Cr Potential Revenue

Accuracy Shipping's 99.80% subsidiary, A.R.S. Terminals (India) Private Limited, has received a Letter of Intent (LoI) from CBIC to set up a Container Freight Station (CFS) at Kandla, Gujarat. The project involves an estimated capex of ₹25 crore (funded via debt and internal accruals), which represents about 41% of the company's current market cap of ₹61 crore. The CFS will feature an annual storage capacity of 80,000 containers and is targeted for commissioning within one year. At peak utilization, management expects the facility to generate ₹175–200 crore in revenue (27-31% of TTM revenue) with double-digit EBITDA margins.

நேர்மறை தாக்கம் 7/10 விரிவாக்கம்

Accuracy Shipping Unit Gets LoI for 80,000 Container/Yr CFS at Kandla Port

Accuracy Shipping's 99.80% subsidiary, A.R.S. Terminals (India) Private Limited, has received a Letter of Intent (LoI) dated September 10, 2026, from the CBIC to set up a Container Freight Station (CFS) at Kandla, Gujarat. The planned facility has a targeted annual handling capacity of approximately 80,000 containers (around 5,000 containers monthly). It is expected to be operationalized within one year from the date of the LoI. Given the company's thin net margin profile (TTM PAT of Rs 4 Cr on Rs 650 Cr revenue), establishing direct terminal handling capacity could support higher-margin integrated logistics operations.

⚠️ இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்